| Valuation method | Value, £ | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 17.40 | 142 |
| Intrinsic value (DCF) | 3.82 | -47 |
| Graham-Dodd Method | n/a | |
| Graham Formula | 9.60 | 33 |
Kyntra Bio, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. The company was founded by Thomas B. Neff on September 29, 1993, and is headquartered in San Francisco, CA.